{
  "trial_id": "NCT02123576",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Hospitalized patients with acute or chronic liver disease",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Type I HRS",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Aged greater than or equal to 18",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Non-pregnant",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Allergy or hypersensitivity to PTX or intolerance to methylxanthines (e.g. caffeine, theophylline)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Concurrent use of nephrotoxic drugs",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Age less than 18",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Pregnancy",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has type 1 diabetes and cardiomyopathy, but no other significant medical issues.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT02123576",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}